Design and execute the proposed experiment to test the hypothesis: 'Neutral Sphingomyelinase-2 Inhibition for Synaptic Protection in Neurodegeneration'. Primary outcome: Synaptic density (PSD-95 puncta/um2) maintained at WT levels (+-15%); MWM latency <=120 s. Estimated cost: $62,000; timeline: 14 months.